Corning and Stevanato Group enter new supply agreement for Corning Valor Glass

Corning Incorporated and Stevanato Group have announced a new collaboration agreement

Corning Incorporated and Stevanato Group are collaborating on the supply of Corning Valor Glass to the pharmaceutical industry.

Corning Incorporated and Stevanato Group have announced a new collaboration agreement focused on supplying Corning Valor Glass to the pharmaceutical industry.
Valor Glass is a high-quality glass container designed for the storage and delivery of injectable drugs. Drug formulations and drug manufacturing processes have evolved significantly over the past century, requiring a stronger, chemically durable, 21st century packaging technology to better protect drug products, including life-saving medicines.
Valor Glass offers superior chemical durability, strength, and damage resistance, resulting in better protection for drug products, according to Corning. Valor Glass enables increased throughput and higher levels of quality assurance for pharmaceutical companies, and higher-quality medicines for patients.
Corning and Stevanato Group have been working together since 2011 to enable higher quality pharmaceutical containers. The latest agreement extends that relationship and combines Stevanato’s state-of-the-art converting technology with Valor Glass to provide pharmaceutical customers with the highest quality pharmaceutical containers.
Franco Stevanato, chief executive officer of Stevanato Group, commented: “Corning and Stevanato Group have a shared commitment to innovation and bringing the highest quality pharmaceutical containers to the industry. Valor is a Type I glass that is well aligned with that shared commitment and we are delighted to be working together on it.”
“Stevanato Group is well respected in this industry because they ensure the highest standards of quality and innovation throughout their production process. We look forward to continuing this work with Stevanato to improve quality in the pharmaceutical glass packaging industry,” said Ron Verkleeren, vice president and general manager, Corning Pharmaceutical Technologies.

Sign up for free to the daily newsletter

Subscribe now to our daily newsletter for full coverage of everything you need to know about the world glass industry!

We don't send spam! Read our Privacy Policy for more information.

Share this article
Related news